| R Rao Gogineni, MD | |
|
3 Cooper Plz, Suite 307, Camden, NJ 08103-1438 | |
| (856) 342-2328 | |
| (856) 541-6137 |
| Full Name | R Rao Gogineni |
|---|---|
| Gender | Male |
| Speciality | Geriatric Psychiatry |
| Experience | 52 Years |
| Location | 3 Cooper Plz, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295823656 | NPI | - | NPPES |
| 010003755 | Other | AMERICHOICE | |
| 092269000 | Other | MEGELLAN | |
| 5352100 | Medicaid | NJ | |
| 1122746 | Other | HORIZON NJ HEALTH | |
| 001663798 | Other | AMERIHEALTH PPO | |
| 260048933 | Other | RR MEDICARE | |
| 0821236000 | Other | AMERIHEALTH HMO, KEYSTONE, IBC | |
| 2388936 | Other | UNITED HEALTHCARE | |
| 33353 | Other | UNIVERSITY HEALTHPLAN | |
| 3K6031 | Other | HEALTHNET | |
| 4478422 | Other | AETNA | |
| P2157639 | Other | OXFORD HEALTH PLAN |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cmc Psychiatric Associates Pc | 2264401686 | 26 |
News Archive
Diagnostic X-rays may increase the risk of developing childhood leukemia, according to a new study by researchers at the University of California, Berkeley's School of Public Health.
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued patent number 7,867,719 entitled "Beta-2 microglobulin as a biomarker for peripheral artery disease" to the Company.
How abnormal protein deposits in the brains of Alzheimer's patients disrupt the signalling between nerve cells has now been reported by researchers in Bochum and Munich, led by Dr. Thorsten M-ller from the Medizinisches Proteom-Center of the Ruhr-Universit-t, in the journal Molecular and Cellular Proteomics. They varied the amount of APP protein and related proteins associated with Alzheimer's disease in cell cultures, and then analysed how this manipulation affected other proteins in the cell.
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has enrolled the first patient in its Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery.
Ontario Nurses' Association President Linda Haslam-Stroud, RN is pleased to announce that a tentative settlement has been reached for 3,000 Registered Nurses and Allied Health Professionals working in 10 of Ontario's Community Care Access Centres.
› Verified 9 days ago
| Entity Name | Cmc Psychiatric Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982646634 PECOS PAC ID: 2264401686 Enrollment ID: O20041001000003 |
News Archive
Diagnostic X-rays may increase the risk of developing childhood leukemia, according to a new study by researchers at the University of California, Berkeley's School of Public Health.
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued patent number 7,867,719 entitled "Beta-2 microglobulin as a biomarker for peripheral artery disease" to the Company.
How abnormal protein deposits in the brains of Alzheimer's patients disrupt the signalling between nerve cells has now been reported by researchers in Bochum and Munich, led by Dr. Thorsten M-ller from the Medizinisches Proteom-Center of the Ruhr-Universit-t, in the journal Molecular and Cellular Proteomics. They varied the amount of APP protein and related proteins associated with Alzheimer's disease in cell cultures, and then analysed how this manipulation affected other proteins in the cell.
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has enrolled the first patient in its Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery.
Ontario Nurses' Association President Linda Haslam-Stroud, RN is pleased to announce that a tentative settlement has been reached for 3,000 Registered Nurses and Allied Health Professionals working in 10 of Ontario's Community Care Access Centres.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| R Rao Gogineni, MD 1 Federal St # 200, Camden, NJ 08103-1088 Ph: (856) 356-4924 | R Rao Gogineni, MD 3 Cooper Plz, Suite 307, Camden, NJ 08103-1438 Ph: (856) 342-2328 |
News Archive
Diagnostic X-rays may increase the risk of developing childhood leukemia, according to a new study by researchers at the University of California, Berkeley's School of Public Health.
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued patent number 7,867,719 entitled "Beta-2 microglobulin as a biomarker for peripheral artery disease" to the Company.
How abnormal protein deposits in the brains of Alzheimer's patients disrupt the signalling between nerve cells has now been reported by researchers in Bochum and Munich, led by Dr. Thorsten M-ller from the Medizinisches Proteom-Center of the Ruhr-Universit-t, in the journal Molecular and Cellular Proteomics. They varied the amount of APP protein and related proteins associated with Alzheimer's disease in cell cultures, and then analysed how this manipulation affected other proteins in the cell.
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has enrolled the first patient in its Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery.
Ontario Nurses' Association President Linda Haslam-Stroud, RN is pleased to announce that a tentative settlement has been reached for 3,000 Registered Nurses and Allied Health Professionals working in 10 of Ontario's Community Care Access Centres.
› Verified 9 days ago
Dr. Thomas Denton Demark, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-342-2328 Fax: 856-541-6137 | |
Nicholas Matthew Adamo, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 800-826-6737 | |
Pamela Szeeley, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-968-7433 | |
John E Bevilacqua, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz, Suite 320, Camden, NJ 08103 Phone: 856-616-1337 | |
Dr. Michael H Goodman, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz, Suite 200, Camden, NJ 08103 Phone: 856-342-2001 Fax: 856-968-2499 | |
Yingcheng Xu, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz Rm 307, Camden, NJ 08103 Phone: 856-342-2328 | |
Teresa J Humaran, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-342-2328 Fax: 856-541-6137 |